The FDA this week approved dabigatran (Pradaxa) for prevention of DVT and pulmonary embolism following hip arthroplasty surgery. The approval follows FDA analysis of two
Author: OrthoBuzz for Surgeons
The connection between patient pain and clinical orthopaedic outcomes has received much attention lately. Here are relevant findings from two recent studies: –An in-press study
When treating shoulders with a Bankart lesion that includes an osseous fragment, many orthopaedic surgeons excise the fragment while repairing the capsulolabral complex, and then
The final rule from the Centers for Medicare & Medicaid Services (CMS) regulating “episode-of-care” Medicare payments to hospitals for hip and knee replacements includes a
In the November 18, 2015 edition of JBJS, Lawing et al. present a well-documented cohort study comparing the outcomes of open-fracture management with local administration
Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature during the previous year in 13 subspecialties.
A recent case-control study in Foot & Ankle International found that high-risk diabetic patients (mean age of 60) undergoing reconstructive foot and/or ankle surgery were
On Monday, Nov. 23, 2015 at 8:00 PM EDT, JBJS will host a one-hour webinar focused on managing pediatric supracondylar humeral fractures. Because supracondylar humeral
In the November 4, 2015 Level I JBJS study by Kukkonen et al., patients over the age of 55 were randomized to one of three
On Thursday, December 10, 2015, from 6:00 to 6:30pm EDT, the Own the Bone initiative will offer a free webinar titled “Vitamin D in Chaos: A Common Sense